Results 151 to 160 of about 1,795,288 (205)

Acute pancreatitis as the initial manifestation of acute myeloid leukemia: a case report and literature review. [PDF]

Front Med (Lausanne)
Chen D, Lin X, Cai X, Huang X, Lin C, Wen R, Zhang X, Li X, Liu L.   +8 more
europepmc   +1 more source

Acute Myeloid Leukemia Subtype-Specific Prognostic Value of NGS in the Setting of Intensive Chemotherapy. [PDF]

Am J Hematol
Bolarinwa A, Al-Kali A, Alkhateeb HB, Mangaonkar AA, Saliba AN, Torghabeh MH, Matin A, Elliott MA, Litzow MR, Hogan WJ, Shah MV, Patnaik MM, Pardanani A, Foran JM, Badar T, Murthy HS, Punwani N, Palmer JM, Sproat LZ, Chen D, Reichard KK, He R, Viswanatha DS, Zepeda-Mendoza CJ, Gangat N, Begna KH, Tefferi A.   +26 more
europepmc   +1 more source

Nine Years of Chronic Myeloid Leukemia in a Young Adult With a Variant Philadelphia Chromosome: A Case Report and Brief Literature Review. [PDF]

Cureus
Izadian Bidgoli A, Gomez Usatorres A, Gomez Veliz A, Gallagher AC, Noriega-Toledo D.   +4 more
europepmc   +1 more source

Therapy-related acute myeloid leukemia with 24-month latency after CD19 CAR-T cell therapy in relapsed/refractory diffuse large B-cell lymphoma: a case report. [PDF]

Front Med (Lausanne)
Su M, Huang C, Zhang Z, Wang X, Jiang P, Chen Y, Wu G.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Venetoclax in acute myeloid leukemia

Expert Opinion on Investigational Drugs, 2023
Background: Substantial progress in the therapeutic arsenal used to treat acute myeloid leukemia became possible in the last decade, as a result of advances in gene editing and descriptive and functional genomics. Objective: The aim of this study is to analyze the efficacy and safety of venetoclax in the treatment of acute myeloid leukemia ...
Bruzzese, Antonella, Martino, Enrica Antonia, Mendicino, Francesco, Lucia, Eugenio, Olivito, Virginia, Neri, Antonino, Morabito, Fortunato, Vigna, Ernesto, Gentile, Massimo   +8 more
openaire   +4 more sources

Acute Myeloid Leukemia

Journal of the National Comprehensive Cancer Network, 2008
Approximately 13,290 people will be diagnosed with acute myeloid leukemia (AML) in 2008, and 8820 patients will die of the disease. As the population ages, the incidence of AML, along with myelodysplasia, appears to be rising. Clinical trials have led to significant treatment improvements in some areas, primarily acute promyelocytic leukemia.
Margaret R, O'Donnell, Frederick R, Appelbaum, Steven E, Coutre, Lloyd E, Damon, Harry P, Erba, James, Foran, Jeffrey, Lancet, Lori J, Maness, Guido, Marcucci, Peter G, Maslak, Michael, Millenson, Joseph O, Moore, Farhad, Ravandi, Friedrich, Schuening, Paul, Shami, B Douglas, Smith, Richard M, Stone, Martin S, Tallman, Eunice, Wang, Frank L, White   +19 more
openaire   +5 more sources

SEPHguarding acute myeloid leukemia

Cell Stem Cell, 2022
Adaptive aberrant gene regulation is a hallmark of malignant growth and therapy resistance in acute myeloid leukemia (AML). In this issue of Cell Stem Cell, Eagle et al. identified oncogenic enhancer-driven overexpression of selenophosphate synthetase 2 (SEPHS2) as an opportunity for targeted mitigation of malignant cell growth in AML.
Malini, Gupta, Britta, Will
openaire   +2 more sources

Acute Myeloid Leukemia

Hematology, 2001
AbstractThrough the hard work of a large number of investigators, the biology of acute myeloid leukemia (AML) is becoming increasingly well understood, and as a consequence, new therapeutic targets have been identified and new model systems have been developed for testing novel therapies.
F R, Appelbaum, J M, Rowe, J, Radich, J E, Dick   +3 more
openaire   +2 more sources

Acute Myeloid Leukemia

Hematology/Oncology Clinics of North America, 2009
The evolution of acute myeloid leukemia (AML) classification reflects greater understanding of the AML pathogenesis. The 2008 World Health Organization classification incorporated cytogenetic and molecular genetic findings and introduced important prognostic correlations.
Amy, Heerema-McKenney, Daniel A, Arber
openaire   +2 more sources

Acute Myeloid Leukemia

Hematology, 2002
AbstractIn this chapter, Drs. Keating and Willman review recent advances in our understanding of the pathophysiology of acute myeloid leukemia (AML) and allied conditions, including the advanced myelodysplastic syndromes (MDS), while Drs. Goldstone, Avivi, Giles, and Kantarjian focus on therapeutic data with an emphasis on current patient care and ...
Francis J, Giles, Armand, Keating, Anthony H, Goldstone, Irit, Avivi, Cheryl L, Willman, Hagop M, Kantarjian   +5 more
openaire   +2 more sources